Revised September 2019
Clinical Trials Network Workgroup
To provide external scientific input and recommendations for current and future research projects of NIDA’s National Drug Abuse Treatment Clinical Trials Network (CTN)
Carlos del Rio, M.D.
Hubert professor and Chair
Hubert Department of Global Health
Rollins School of Public Health
Hillary Kunins, M.D.
NYC Department of Health and Mental Hygiene
Albert Einstein College of Medicine
Barbara Cimaglio, BA
Access to Medication-Assisted Treatment
Division of Substance Use Prevention and Recovery
Illinois Department of Human Services
Dennis McCarty, Ph.D.
Department of Public Health and Preventive Medicine
Oregon Health & Science University
Division of Therapeutics and Medical Consequences Workgroup
To provide scientific input on the current and future research portfolio for NIDA’s Division of Therapeutics and Medical Consequences.
To provide input on the development of medications and devices to treat SUD and review concepts and recommend emerging pharmacotherapies, behavioral therapies and devices to treat SUD.
Kalpana Merchant, Ph.D.
Chief Scientific Officer
Lisa Gold, Ph.D.
Retired - Merck
David McKinzie, Ph.D.
Professor of Pharmacology & Toxicology
Indiana University School of Medicine
Stark Neurosciences Research Institute
Chris Schmidt, Ph.D.
Retired - Pfizer